1. Home
  2. Universitat de Barcelona
  3. Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)
  4. View Item

Cancer: Limitations of therapies exposed

Author

Casanovas i Casanovas, Oriol

Publication date

2020-11-02T09:44:09Z

2020-11-02T09:44:09Z

2012-04-01

2020-10-29T15:04:25Z

Share

Abstract

Anti-angiogenic drugs, used for cancer treatment, target blood-vessel formation in tumours. Two studies commented here show that such drugs can reduce the efficiency of other anticancer agents and increase the aggressiveness of tumours.

Document Type

Article

Accepted version

Language

English

Subjects and keywords

Angiogènesi; Medicaments antineoplàstics; Tumors; Neovascularization; Antineoplastic agents

Publisher

Springer Science and Business Media LLC

Related items

Versió postprint del document publicat a: https://doi.org/10.1038/484044a

Nature, 2012, vol. 484, issue. 7392, p. 44-46

https://doi.org/10.1038/484044a

info:eu-repo/grantAgreement/EC/FP7/281830/EU//STROMALIGN

Recommended citation

This citation was generated automatically.

Export

DIDL MARC MARC_CCUC METS OAI_DC ORE QDC RDF

Rights

(c) Springer Science and Business Media LLC, 2012

This item appears in the following Collection(s)

Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL) [6905]

ISGlobal - Institut de Salut Global de Barcelona [61307]